index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Modificateurs de gènes Muscle development Duchenne DMD dystrophy Antisense oligonucleotides CD38 Energy Metabolism/drug effects Duchenne muscular dystrophy DMD Gene modifiers Duchenne muscular dystrophy DMD LncARN Inbred C57BL Molecular Sequence Data Morphogenesis Mice BMD CaV subunits Humans Muscle Biology Myotendinous junction Becker muscular dystrophy Dystrophie Musculaire de Duchenne DMD Cell Biology Hepatocellular carcinoma Ex-vivo Myogenesis Long QT Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Muscle Strength Dystrophie Musculaire de Becker BMD Delivery Skeletal muscle Epigenetics Drp1 Mdx mouse Cultured Genomic Cell Line Gene Expression Regulation/drug effects Knockout Génomique Inbred mdx Becker BMD muscular dystrophy CTNNB1 Invivo Muscular dystrophy DHPR α1S Male Base Sequence Muscular Dystrophy Dystrophin Dynamin 2 LncRNA Human Umbilical Vein Endothelial Cells LKB1 Hear NAD+ Animals Cardiomyopathie Multiresolution modeling Dystrophine Mitochondrial fission Calcium Channels Becker muscular dystrophy BMD Long noncoding RNA Metabolism Cardiomyopathy Centronuclear myopathy Molecular docking Liver Clinical trials Gene expression Dystrophin central domain Animal/physiopathology Muscular Atrophy Multi resolution modeling NNOS Inhibitors CaVβs Exon skipping Muscles/physiopathology MES Muscle Diseases Cells Cachexia Calcium MiARN Immunoglobulin Fc Fragments/pharmacology Dystrophin-EGFP DMO Allele‐specific silencing therapy L-Type Activin Receptors Autophagy Multi exon skipping Dystrophy Cell homeostasis Homeostasis Dystrophie musculaire de Becker